fbpx Yourgene Health plc - Home
previous arrow
next arrow

As many have already said and written, this year has been like none other. This has been especially true for conferences and exhibitions. Every year, the commercial team at Yourgene look forward to exhibiting at various conferences globally. It’s a chance to meet our partners and customers, as well as form new relationships. With the COVID-19 pandemic none of this was possible, so when we heard that the Taiwan Healthcare Expo was still going ahead, we jumped at the opportunity to attend it with a bang! We had so much we wanted to share! Preparation and planning started a few months before the actual exhibition, to ensure all our efforts were in line with the overall strategic plans. 

Closer to the opening of the conference, the marketing team were in constant touch ensuring materials arrived and were printed on time. This year a lot of the coordination had to be done remotely from our Singapore office – another challenge faced down to COVID, even though incident rates are still low in Taiwan. Ordinarily we would have loved to have our broader commercial team and our CEO Lyn Rees visit and attend the event – he loves getting to meet our teams and our customers. But due to the restrictions with the global travel we were sadly unable to make this a truly global event. 

Lyn Rees, CEO of Yourgene commented “I am so thrilled to see the success of the Taiwan Health Expo – one of our only events this year. We’ve really missed our conferences and being able to meet our customers and our partners. Business is all about people and building relationships, this is so difficult to do remotely, so it’s fantastic that the team were able to spend time showcasing our new products and services and listening to what our customers want. Really looking forward to being able to travel again and getting over to Taiwan to continue to support the team in building these key partnerships.”

Your Comment

Your Comment

Thanks to our committed team in Taipei and Singapore, the event was a huge success, with a number of highlights. One of the most exciting was probably the Vice-President of Taiwan, Vice President Lai Ching-te visiting the stand and speaking to Dr Bill Chang, Chief Entrepreneur. Bill introduced Yourgene and our expertise in molecular testing as well as servicing the Taiwan Biobank project. Bill was also able to present Yourgene to Former Vice President Chien-jen who thanked the company for its contribution in the biobank project.

Your Comment

Your Comment

Bill also gave a podium presentation about the power of Taiwan Precision Testing (LDTs) industries; how to accelerate precision testing industries strategic partnership to accelerate growth, adopting smart technology, to scale up and internationalise the industry with a feasible business model for overseas expansion of precision medicine.

Your Comment

Over the course of the exhibition, we had a number of on-booth presentations from key external and internal speakers. We were very excited to have experts in their field including Mr Allen Cheng, from ATGENOMIX, Dr. Chia-Hsiang Chen from Linkou Chang Gung Memorial Hospital, Dr. Sen-Lin Tang - Biodiversity Research Center, Academia Sinica and Dr. Chi-Cheng Huang from the Taipei Veterans General Hospital share their knowledge with our delegates. They spoke on a range of topics such as: metagenomic sequencing services from our Taipei lab; our range of qPCR products for reproductive health, including Male Factor Infertility, Recurrent Pregnancy Loss and Rapid Aneuploidy Analysis; Clarigene: COVID-19 testing solution for low to high throughput laboratories. 

We made a special showcase for the Yourgene QS250 and we were lucky enough to have a demonstration kit on display on the booth. This made it a much more interactive conversation with visitors and formed the basis of many discussions. The Yourgene QS250 is a game changer for sample preparation. With three protocols in one bench-based platform it performs gel size selection, fragment analysis and solution-based fluorescence assays. It can be used across multiple platforms from NIPT workflows, cancer detection and cancer disease progression and quality control for NGS workflows.

Your Comment

The team were also able to really showcase the new Naso-pharnygeal carcinoma (NPC) test that we have added to our clinical service for patients in Taiwan. The Take2 Prophecy Test for NPC is the only early cancer screening test for NPC that is validated by a large-scale clinical trial on asymptomatic individuals. It was a great platform for us to speak with clinicians about the benefits of early non-symptomatic screening. Learn more about our nPC test, please click here. As this was one of our only events this year, we had a videographer present and he made a fantastic series of short films for us from around the event. These can be seen here. Taiwan Health Expo 2020 may have been one of the very few exhibitions we were able to go to this year, but it didn’t disappoint. With commitment and teamwork, two core values that we live by at Yourgene, we were able to make this a definite highlight in our calendar. Next year, we’re hoping to see more of our customers and partners face to face, for a full list of conferences we attend, please visit https://www.yourgene-health.com/about/events

  • Ranger® Revolution - LightBench® Detect is here! - 20 June 2022 +

    Ranger® Revolution - LightBench® Detect is Here!

    The wait is over! Yourgene Health are proud to today reveal the Ranger® Revolution in the form of the LightBench® Detect; the latest addition to our Ranger® Technology portfolio. We’ve worked closely with our clinical laboratory partners to develop a size selection instrument that is optimised for improving the performance of liquid biopsy workflows, most notably non-invasive prenatal testing (NIPT). The LightBench® Detect addresses a pressing need for NIPT

    Read More
  • Collaboration to Perform: Yourgene Microdeletions Plugin Accelerator - 24 May 2022 +

    Yourgene Health is today unveiling the Yourgene Microdeletions Plugin Accelerator phase, following a successful pilot project with LifeStrands Genomics. This Accelerator represents a new era in Yourgene’s approach to delivery of NIPT testing solutions, with a focus on ‘Collaboration to Perform’. Working as a partnership, rather than the traditional laboratory/manufacturer relationship, represents a shared commitment to ensuring high-quality and performance-driven testing, ultimately delivering better outcomes for patients.

    The Plugin has been designed for use with

    Read More
  • Exclusion criteria for NIPT explained - 15 February 2022 +

    The IONA ® test is a non-invasive prenatal test (NIPT) for pregnant women which estimates the risk of a fetus having Down’s syndrome (Trisomy 21), Edwards’ syndrome (Trisomy 18) and Patau’s syndrome (Trisomy 13). The test is performed by analysing cell-free placental-fetal DNA from a maternal blood sample. The test is suitable for women who are at least 10 weeks pregnant, prior to ten weeks there is a risk that there would be insufficient placental-fetal cell

    Read More
  • International Women and Girls in Science Day 2022 +

    Here at Yourgene Health, we are very proud that a large proportion of our genomic technologies and services business, including senior leadership and laboratory managers, are powerful women. We believe it is important to showcase the impressive range of talent we are lucky to have, including our women and girls in science.

    In light of the International Day of Women and Girls in Science, we would like to place a spotlight on a few members

    Read More
  • New Year, New Regulations - 19 January 2022 +

    The ‘New Year's resolution’ is a tradition almost all of us are familiar with, in which a person resolves to accomplish a personal goal, continue good habits or change undesirable ones all with the intention of self-improvement. A study of over 800 million activity data points on the exercise platform Strava found that today, January 19th, is the most common day for a New Year’s resolution to be abandoned ( 1 ). If you are reading this

    Read More
  • Behind the scenes: Adapting diagnostic services during a pandemic - 11 November 2021 +

    The diagnostic testing business has always been dynamic and opportunistic , but nothing could have stretched the definition of these 2 words like a pandemic.

    Since the launch of Yourgene Genomic Services 6 months into this global pandemic – born from a legacy, well established NIPT service laboratory, a modest acquisition, and an unprecedented national genomic testing demand, we have vastly expanded our testing capacity by converting every spare inch of underutilised office space created by remote

    Read More
  • Overprescribing within the NHS - 02 November 2021 +

    “Good for you, good for us but is it good for everybody?”
    Overprescribing within the NHS – October 2021

    The NHS is currently the 5th largest global employer; with over 1.3m employees and receiving around 10% of the UK Government’s annual spending. It is estimated that the NHS deals with 336 million ‘patient visits’ per year, - many of whom will receive some form of at least one ‘prescription’ per visit and at a current charge in

    Read More
  • The role genomics plays in relationships - 18 August 2021 +

    According to National Today, the website dedicated to highlighting every day celebrations and holidays, August 18 th is ‘National Couple’s Day’ – a day to celebrate the important relationships in life. Whilst not an official holiday or observance in any country, the clinical team at Yourgene Health wanted to use this opportunity to reflect upon the pivotal role that genomics plays in relationships across the world.

    Earlier this year a study, published in Nature Human Behaviour,

    Read More
  • NIPT for Sex Chromosome Aneuploidies and Autosomal Aneuploidies. A Q&A with Dr Greg Fitzgibbon - 26 May 2021 +

    Yourgene Health has recently launched IONA ® Care , an advanced prenatal screening test that performs whole-genome analysis to measure the likelihood that a pregnant woman is carrying a fetus with one the most common trisomies (trisomy 21, 18 and 13), any other Autosomal Aneuploidy (AA) or a Sex Chromosome Aneuploidy (SCA). IONA ® Care is available from the Yourgene Genomic Services laboratory in Manchester, UK. The test is available as a menu, enabling pregnant women, their families

    Read More
  • COVID-19 testing and the need for regulation - 6 May 2021 +

    The COVID-19 pandemic presented huge challenges worldwide. In response to the unprecedented need for COVID-19 PCR testing, the UK government set up a new network of Lighthouse laboratories across the country to provide the required capacity for testing thousands of samples each day. These laboratories proved a vital part of the test and trace strategy but were also under immense pressure to meet their targets and, following an investigation by Panorama , it was found that

    Read More
  • Yourgene on World Creativity and Innovation Day 2021 - 21 April 2021 +

    Innovation and creativity are two pillars at the heart of technological and scientific advances. The instrumental role they play has been recognised by the United Nations (UNN), who have designated a special day to raise awareness of the importance of innovation in culture and economic growth worldwide: 21st April. World Creativity and Innovation Day (UNN) is a day to encourage people to “think outside the box”, find new perspectives which push personal growth, identify different

    Read More
  • The IONA® test recommended for twin pregnancies screening for Down’s syndrome - 7 April 2021 +

    In recent years, fertility treatments and the fact women are having babies later has made multiple births more common. In 2016, around 12,000 sets of twins and about 190 sets of triplets or more were born in the UK. That means about 1 in every 65 births in the UK today are twins, triplets or more. 1 Extensive studies have been carried out for cell-free DNA (cfDNA) testing in singleton pregnancies with sample numbers into

    Read More
  • Blood clots, inherited thrombophilia and COVID-19 - 25 March 2021 +

    Recent reports in the media from a collection of European countries suggest that there may be cause for concern with regards to the Oxford AstraZeneca COVID-19 vaccine and abnormal blood clotting. According to Norway’s medicines agency (NoMA), four new cases of “serious blood clotting in adults” have been identified following a recent review (1). Austria have suspended the use of one particular batch of the vaccine after two events, including an individual diagnosed with multiple

    Read More
  • COVID-19 strains - what are they and why do they matter? A Q&A with Dr Michael Risley - 28 January 2021 +

    The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the beginning of the global COVID-19 outbreak, the diagnostic and research community has undertaken an unprecedented effort to understand how best to manage, eradicate and prevent the disease. In recent months we have seen the rollout of ambitious vaccination schedules worldwide, as well as the strengthening of

    Read More
  • So much to be proud of! - 23 December 2020 +

    As many have already said and written, this year has been like none other. This has been especially true for conferences and exhibitions. Every year, the commercial team at Yourgene look forward to exhibiting at various conferences globally. It’s a chance to meet our partners and customers, as well as form new relationships. With the COVID-19 pandemic none of this was possible, so when we heard that the Taiwan Healthcare Expo was still going ahead,

    Read More
  • 1
  • 2